New Drug for Type 2 Diabetes

• Autores: Diane S. Aschenbrenner
• Localización: American Journal of Nursing, ISSN 0002-936X, Vol. 114, Nº. 8, 2014, págs. 21-22
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • * Albiglutide (Tanzeum), a glucagon-like peptide-1 agonist, has been approved by the FDA for the treatment of type 2 diabetes.

    * Patients who have a personal or family history of medullary thyroid carcinoma shouldn't be prescribed albiglutide.